The Singapore FinTech Festival (SFF) and the Singapore Week of Innovation and TeCHnology (SWITCH) concluded its combined...
Duke-NUS Medical School’s PhD programme in Clinical Sciences (PhD CS) addresses an important need in the field, by...
Biofourmis has announced that it has reached an agreement to acquire Zürich, Switzerland-based Biovotion AG, develo...
Singapore founded Biofourmis, global leader in digital therapeutics based in Boston, announced that it has been selected...
Novotech, the Asia-Pacific CRO, has again won the prestigious Asia-Pacific CRO of the year awarded by leading analyst fi...
Nanyang Technological University, Singapore (NTU Singapore) scientists have discovered that a type of immune cell know...
The growing consumer desire for more product variety and packaging sizes is creating a need for smaller, more flexible m...
Automated cell counters are electronic devices that can automatically count the cells of humans, animals, plants, bacter...
The flagship National University of Singapore (NUS) Grandes Écoles French Double Degree Programme (FDDP), the lon...
Global BioLife Inc, the U.S. subsidiary of Singapore eDevelopment Ltd (SeD), will present its 3F Antimicrobial Fra...
Abbott is partnering with Diabetes Singapore to empower individuals with diabetes and their caregivers with information ...
The most economical and simple way to manage health problems can often be the most difficult to implement because they r...
Singapore’s Diabetes Study in Nephropathy and other Microvascular Complications (DYNAMO), fronted by Lead Principa...
Sanofi on 13 Nov 2019, announced the launch of SOLIQUA®, its once-daily injectable treatment which aims to reli...
Advanced MedTech Holdings (AMTH), Southeast Asia's largest medical device business headquartered in Singapore,...
The Singapore FinTech Festival (SFF) and the Singapore Week of Innovation and TeCHnology (SWITCH) has come together for ...
Stone Capital and Biosyngen have partnered to establish a Biopharmaceutical Investment Fund in Singapore, the signi...
Vela Diagnostics announced on 5 Nov 2019, that it has received FDA authorization to market its in vitro d...
